Editas Medicine
Editas Medicine is a leading genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.

Year Established: 2013
Stock Ticker: EDIT
Exchange: NASDAQ
